High-precision equipment engineered for modern molecular biology and clinical labs.
The global Next Generation Sequencing (NGS) market has transitioned from a specialized research tool to a fundamental pillar of clinical diagnostics. Today, NGS systems are at the forefront of the precision medicine revolution, enabling rapid whole-genome sequencing (WGS), targeted resequencing, and transcriptome analysis. As a leading Custom OEM NGS System factory, we recognize the shifting industrial landscape where high-throughput capabilities must be balanced with cost-efficiency and localized accessibility.
From oncology profiling and rare disease diagnosis to non-invasive prenatal testing (NIPT) and infectious disease surveillance, the demand for robust, scalable sequencing platforms is skyrocketing. The industrial status of NGS is no longer defined just by the sequencers themselves, but by the entire workflow—automated library preparation, high-purity diagnostic reagents, and intelligent data analysis. Our factory provides the infrastructure required to support this end-to-end ecosystem.
Staying ahead in the NGS sector requires a deep understanding of technological trajectories.
Manual library preparation is the biggest bottleneck in NGS workflows. We are seeing a massive shift toward systems like our Eosbot Seq24, which automate the complex steps of fragmentation, ligation, and amplification to eliminate human error.
There is a growing global demand for benchtop NGS systems that allow hospitals and regional clinics to perform sequencing locally rather than sending samples to massive central laboratories.
The industry is moving beyond just DNA. Future systems are being optimized to handle RNA-Seq, epigenetics, and proteomics simultaneously, providing a holistic view of biological systems.
In the competitive NGS market, global procurement managers face three primary challenges: supply chain stability, cost-to-performance ratio, and regulatory compliance.
As a specialized manufacturer based in Ningbo, China, Ningbo Medvok Medical Co., Ltd. offers unique advantages that Western-only manufacturers often cannot match:
By choosing a Chinese factory with ISO 13485 management, international clients receive the reliability of global standards combined with the agility and cost-benefits of China's advanced industrial infrastructure.
Where our systems make a tangible difference in human health.
Our sequencing systems enable localized hospitals to perform Comprehensive Genomic Profiling (CGP) to match cancer patients with targeted therapies, reducing turnaround times from weeks to days.
During outbreaks, our automated PCR and NGS systems allow public health departments to track viral mutations in real-time, providing critical data for vaccine development and containment.
Beyond human medicine, our OEM systems are used in industrial agriculture for crop strain validation and livestock genetic screening, ensuring food security and quality.
Ningbo Medvok Medical Co., Ltd. is a high-tech biotechnology company focused on the R&D and production of antigens, antibodies and downstream detection reagents for diagnosis and therapy. Our product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, from raw materials to finished products.
Innovation is in our DNA! Bioantibody keeps developing new technologies. Currently, our products have been delivered to more than 60 countries and cities worldwide. Using the ISO 13485 management system, the product quality is greatly trusted by customers. With the mission "Biotech For A Better Life", we are committed to innovation and providing our best solutions to our customers. We sincerely believe we could make our special contribution to human ecology and health.
Furthermore, our economic development will be compatible with proper conduct in relation to ethics, society, the workplace, the environment and respect for human rights. We think of society as a group of individuals with equal rights and opportunities. In order to materialize this commitment, we have developed the sustainability policy on environmental and social matters.
Standardized and custom systems for pharmaceutical and diagnostic reagent production.
Medvok Medical
